PGT-A:它是为了什么,有什么问题?

Stéphane Viville1,2, Mohamed Aboulghar3,4

  • 1Laboratoire de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, UF3472-Génétique de L'infertilité, 67000, Strasbourg, France. stephane.viville@unistra.fr.

概括

预植入基因测试 (PGT-A) 是为了通过选择euploid胚胎来提高试管婴儿的成功而开发的. 然而,目前的证据表明,PGT-A提供了最小的益处,甚至可能减少试管婴儿的结果,质疑其临床价值.

相关概念视频

Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.7K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K